Cerezen™, a non-drug treatment, improved both memory and independent functioning. Results persisted for 1 year and are ...

The Forum on Neuroscience and Nervous System Disorders hosted a public session at the 2011 Alzheimer's Association International Conference to identify a set of core principles that could be used to ...

Mayo Clinic researchers validated an FDA-approved blood test that diagnoses Alzheimer’s disease with 95% sensitivity and 82% specificity in outpatient settings. The test offers a less invasive and ...

Traditional approaches for detecting Alzheimer’s disease (AD) that rely on examining the brain for amyloid plaques have limitations in accuracy and early detection. Although the industry has ...

Data Across 29 Presentations Highlights Precision, Accessibility and Platform-Agnostic Adoption, Establishing ALZpath's Proprietary pTau217 as a Highly Accurate Industry Benchmark CARLSBAD, Calif., ...

The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve brain health, today announced they will work with Janssen Research & ...

Mutations that accumulate in blood cells with age and raise the risk of leukemia and lymphoma can also colonize the brain’s ...

Researchers have identified two FDA-approved cancer drugs, letrozole and irinotecan, that reversed Alzheimer’s-related brain ...

Study finds that sleep habits directly interact with genes to determine the rate of grey matter loss and cognitive decline.

In 822 deceased older adults from ROS and MAP, researchers linked stable psychological traits to multi-omic molecular ...